Form D · Other Health Care

Pathfinder Therapeutics, Inc.

Nashville, TN · CIK 0001492896

Offering snapshot reported Jun 21, 2013 · SEC filing

Reported sold
$1.24M
Offering amount: $1.77M
Investors reported
7
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 7, 2013
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 21, 2013Initial$1,243,879No comparison7SEC filing
May 10, 2012Initial$5,316,190No comparison8SEC filing
May 27, 2010Amendment$3,024,162-$1vs May 27, 20107SEC filing
May 27, 2010Initial$3,024,163No comparison7SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-198401

Source: Form D, filed Jun 21, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Naji Abumrad Director
Marc Buntaine Director
James Cloar Director
Joe Cook Iii Director
Joseph Cook, Iii Director
Johnny Drake Executive
Bob Galloway Director
Curtis "Skip" Goode Director, Executive
Richard Molloy Director
Robert Morff Director, Promoter
Bob Morff Director
Bob Mortt Director
Christopher Rand Director
Jim Stefansic Executive, Promoter
James D Stefansic Executive
Clay Thorp Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
2969 Armory Drive Suite 100 A
Nashville, TN, 37204